跳转至内容
Merck
CN

I8140

IgG 来源于兔血清

technical grade, ≥80% (SDS-PAGE), buffered aqueous solution

别名:

兔 IgG

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352203
NACRES:
NA.46
MDL number:
Conjugate:
unconjugated
Species reactivity:
-
Application:
Citations:
95
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


conjugate

unconjugated

Quality Level

grade

technical grade

assay

≥80% (SDS-PAGE)

form

buffered aqueous solution

shipped in

dry ice

storage temp.

−20°C

Application

兔血清IgG已被用于:
  • 作为参考物质、标准品或阻断剂,适用于许多免疫检测,包括斑点印迹、ELISA、蛋白质免疫印迹、IEP和免疫扩散检测
  • 阿蒂斯反应
  • 染色质免疫沉淀

Biochem/physiol Actions

免疫球蛋白G(IgG)可调节免疫应答,如吞噬作用,并且还与自身免疫疾病的发展有关。 IgG1可调节小鼠的补体结合。

Physical form

0.01 M磷酸盐缓冲液(pH 7.2,含有15 mM叠氮化钠)溶液

Preparation Note

从合并的正常兔血清中分级纯化兔IgG

Analysis Note

免疫电泳(IEP)被用于鉴定兔IgG。与抗兔全血清和抗兔IgG相比,在γ区有一条主要的沉淀弧。与抗兔全血清相比,可能存在较小的γ弧

Disclaimer

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。


Still not finding the right product?

Explore all of our products under IgG 来源于兔血清


存储类别

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

低风险生物材料

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库


相关内容


Frances Rena Bahjat et al.
Arthritis and rheumatism, 58(5), 1433-1444 (2008-04-29)
To assess whether R788, an orally bioavailable small molecule inhibitor of spleen tyrosine kinase (Syk)-dependent signaling, could modulate disease in lupus-prone (NZB x NZW)F1 (NZB/NZW) mice via inhibition of Fc receptor (FcR) and B cell receptor signaling. R788 was administered
Elena Matveeva et al.
Cell discovery, 2, 15046-15046 (2016-07-28)
Specialized chromatin structures such as nucleosomes with specific histone modifications decorate exons in eukaryotic genomes, suggesting a functional connection between chromatin organization and the regulation of pre-mRNA splicing. Through profiling the functional location of Poly (ADP) ribose polymerase, we observed
Aluya R Oseghale et al.
Blood cells, molecules & diseases, 79, 102345-102345 (2019-07-28)
Pharmacologic induction of fetal hemoglobin (HbF) is an effective strategy for treating sickle cell disease (SCD) by ameliorating disease severity. Hydroxyurea is the only FDA-approved agent that induces HbF, but significant non-responders and requirement for frequent monitoring of blood counts



全球贸易项目编号

货号GTIN
I8140-10MG04061833858479
I8140-50MG04061833858486